Anti-TGF Monoclonal Antibody (GC1008) in Relapsed Malignant Pleural Mesothelioma

Clinical trial NCT01112293 · COMPLETED

Trial details

NCT number: NCT01112293
Sponsor: Abramson Cancer Center at Penn Medicine
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pleural Malignant Mesothelioma

Start date: 2010-04-01
Primary completion: 2012-10-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.